img

Global PDE 4 Inhibitors Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global PDE 4 Inhibitors Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

PDE 4 Inhibitors report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global PDE 4 Inhibitors market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Psoriasis and Chronic Obstructive Pulmonary Disease (COPD) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for PDE 4 Inhibitors industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, PDE 4 Inhibitors key manufacturers include Pfizer(Anacor), Arcutis Biotherapeutics, UNION Therapeutics, Innovent Biologics, Inc., Amgen, Ralington pharma LLP, Beijing Biolab Technology Co., Ltd., Nycomed and Forest, etc. Pfizer(Anacor), Arcutis Biotherapeutics, UNION Therapeutics are top 3 players and held % sales share in total in 2022.
PDE 4 Inhibitors can be divided into Rolipram, Tetomilast, Cilomilast and Criborole, etc. Rolipram is the mainstream product in the market, accounting for % sales share globally in 2022.
PDE 4 Inhibitors is widely used in various fields, such as Psoriasis, Chronic Obstructive Pulmonary Disease (COPD), Asthma and Ankylosing Spondylitis (AS), etc. Psoriasis provides greatest supports to the PDE 4 Inhibitors industry development. In 2022, global % sales of PDE 4 Inhibitors went into Psoriasis filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global PDE 4 Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer(Anacor)
Arcutis Biotherapeutics
UNION Therapeutics
Innovent Biologics, Inc.
Amgen
Ralington pharma LLP
Beijing Biolab Technology Co., Ltd.
Nycomed
Forest
Bristol Myers
GSK
Segment by Type
Rolipram
Tetomilast
Cilomilast
Criborole
Apremilast
Roflumilast
Others

Segment by Application


Psoriasis
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Ankylosing Spondylitis (AS)
Inflammatory Bowel Disease (IBD)
Atopic Dermatitis
Rheumatoid Arthritis (RA)
Systemic Lupus Erythematosus (SLE)
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the PDE 4 Inhibitors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of PDE 4 Inhibitors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the PDE 4 Inhibitors industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of PDE 4 Inhibitors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, PDE 4 Inhibitors introduction, etc. PDE 4 Inhibitors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of PDE 4 Inhibitors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 PDE 4 Inhibitors Market Overview
1.1 PDE 4 Inhibitors Product Overview
1.2 PDE 4 Inhibitors Market Segment by Type
1.2.1 Rolipram
1.2.2 Tetomilast
1.2.3 Cilomilast
1.2.4 Criborole
1.2.5 Apremilast
1.2.6 Roflumilast
1.2.7 Others
1.3 Global PDE 4 Inhibitors Market Size by Type
1.3.1 Global PDE 4 Inhibitors Market Size Overview by Type (2024-2034)
1.3.2 Global PDE 4 Inhibitors Historic Market Size Review by Type (2024-2024)
1.3.3 Global PDE 4 Inhibitors Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America PDE 4 Inhibitors Sales Breakdown by Type (2024-2024)
1.4.2 Europe PDE 4 Inhibitors Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific PDE 4 Inhibitors Sales Breakdown by Type (2024-2024)
1.4.4 Latin America PDE 4 Inhibitors Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa PDE 4 Inhibitors Sales Breakdown by Type (2024-2024)
2 Global PDE 4 Inhibitors Market Competition by Company
2.1 Global Top Players by PDE 4 Inhibitors Sales (2024-2024)
2.2 Global Top Players by PDE 4 Inhibitors Revenue (2024-2024)
2.3 Global Top Players by PDE 4 Inhibitors Price (2024-2024)
2.4 Global Top Manufacturers PDE 4 Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 PDE 4 Inhibitors Market Competitive Situation and Trends
2.5.1 PDE 4 Inhibitors Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by PDE 4 Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PDE 4 Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into PDE 4 Inhibitors Market
2.8 Key Manufacturers PDE 4 Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 PDE 4 Inhibitors Status and Outlook by Region
3.1 Global PDE 4 Inhibitors Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global PDE 4 Inhibitors Historic Market Size by Region
3.2.1 Global PDE 4 Inhibitors Sales in Volume by Region (2024-2024)
3.2.2 Global PDE 4 Inhibitors Sales in Value by Region (2024-2024)
3.2.3 Global PDE 4 Inhibitors Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global PDE 4 Inhibitors Forecasted Market Size by Region
3.3.1 Global PDE 4 Inhibitors Sales in Volume by Region (2024-2034)
3.3.2 Global PDE 4 Inhibitors Sales in Value by Region (2024-2034)
3.3.3 Global PDE 4 Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global PDE 4 Inhibitors by Application
4.1 PDE 4 Inhibitors Market Segment by Application
4.1.1 Psoriasis
4.1.2 Chronic Obstructive Pulmonary Disease (COPD)
4.1.3 Asthma
4.1.4 Ankylosing Spondylitis (AS)
4.1.5 Inflammatory Bowel Disease (IBD)
4.1.6 Atopic Dermatitis
4.1.7 Rheumatoid Arthritis (RA)
4.1.8 Systemic Lupus Erythematosus (SLE)
4.1.9 Others
4.2 Global PDE 4 Inhibitors Market Size by Application
4.2.1 Global PDE 4 Inhibitors Market Size Overview by Application (2024-2034)
4.2.2 Global PDE 4 Inhibitors Historic Market Size Review by Application (2024-2024)
4.2.3 Global PDE 4 Inhibitors Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America PDE 4 Inhibitors Sales Breakdown by Application (2024-2024)
4.3.2 Europe PDE 4 Inhibitors Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific PDE 4 Inhibitors Sales Breakdown by Application (2024-2024)
4.3.4 Latin America PDE 4 Inhibitors Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa PDE 4 Inhibitors Sales Breakdown by Application (2024-2024)
5 North America PDE 4 Inhibitors by Country
5.1 North America PDE 4 Inhibitors Historic Market Size by Country
5.1.1 North America PDE 4 Inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America PDE 4 Inhibitors Sales in Volume by Country (2024-2024)
5.1.3 North America PDE 4 Inhibitors Sales in Value by Country (2024-2024)
5.2 North America PDE 4 Inhibitors Forecasted Market Size by Country
5.2.1 North America PDE 4 Inhibitors Sales in Volume by Country (2024-2034)
5.2.2 North America PDE 4 Inhibitors Sales in Value by Country (2024-2034)
6 Europe PDE 4 Inhibitors by Country
6.1 Europe PDE 4 Inhibitors Historic Market Size by Country
6.1.1 Europe PDE 4 Inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe PDE 4 Inhibitors Sales in Volume by Country (2024-2024)
6.1.3 Europe PDE 4 Inhibitors Sales in Value by Country (2024-2024)
6.2 Europe PDE 4 Inhibitors Forecasted Market Size by Country
6.2.1 Europe PDE 4 Inhibitors Sales in Volume by Country (2024-2034)
6.2.2 Europe PDE 4 Inhibitors Sales in Value by Country (2024-2034)
7 Asia-Pacific PDE 4 Inhibitors by Region
7.1 Asia-Pacific PDE 4 Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific PDE 4 Inhibitors Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific PDE 4 Inhibitors Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific PDE 4 Inhibitors Sales in Value by Region (2024-2024)
7.2 Asia-Pacific PDE 4 Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific PDE 4 Inhibitors Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific PDE 4 Inhibitors Sales in Value by Region (2024-2034)
8 Latin America PDE 4 Inhibitors by Country
8.1 Latin America PDE 4 Inhibitors Historic Market Size by Country
8.1.1 Latin America PDE 4 Inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America PDE 4 Inhibitors Sales in Volume by Country (2024-2024)
8.1.3 Latin America PDE 4 Inhibitors Sales in Value by Country (2024-2024)
8.2 Latin America PDE 4 Inhibitors Forecasted Market Size by Country
8.2.1 Latin America PDE 4 Inhibitors Sales in Volume by Country (2024-2034)
8.2.2 Latin America PDE 4 Inhibitors Sales in Value by Country (2024-2034)
9 Middle East and Africa PDE 4 Inhibitors by Country
9.1 Middle East and Africa PDE 4 Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa PDE 4 Inhibitors Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa PDE 4 Inhibitors Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa PDE 4 Inhibitors Sales in Value by Country (2024-2024)
9.2 Middle East and Africa PDE 4 Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa PDE 4 Inhibitors Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa PDE 4 Inhibitors Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer(Anacor)
10.1.1 Pfizer(Anacor) Company Information
10.1.2 Pfizer(Anacor) Introduction and Business Overview
10.1.3 Pfizer(Anacor) PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Pfizer(Anacor) PDE 4 Inhibitors Products Offered
10.1.5 Pfizer(Anacor) Recent Development
10.2 Arcutis Biotherapeutics
10.2.1 Arcutis Biotherapeutics Company Information
10.2.2 Arcutis Biotherapeutics Introduction and Business Overview
10.2.3 Arcutis Biotherapeutics PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Arcutis Biotherapeutics PDE 4 Inhibitors Products Offered
10.2.5 Arcutis Biotherapeutics Recent Development
10.3 UNION Therapeutics
10.3.1 UNION Therapeutics Company Information
10.3.2 UNION Therapeutics Introduction and Business Overview
10.3.3 UNION Therapeutics PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.3.4 UNION Therapeutics PDE 4 Inhibitors Products Offered
10.3.5 UNION Therapeutics Recent Development
10.4 Innovent Biologics, Inc.
10.4.1 Innovent Biologics, Inc. Company Information
10.4.2 Innovent Biologics, Inc. Introduction and Business Overview
10.4.3 Innovent Biologics, Inc. PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Innovent Biologics, Inc. PDE 4 Inhibitors Products Offered
10.4.5 Innovent Biologics, Inc. Recent Development
10.5 Amgen
10.5.1 Amgen Company Information
10.5.2 Amgen Introduction and Business Overview
10.5.3 Amgen PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Amgen PDE 4 Inhibitors Products Offered
10.5.5 Amgen Recent Development
10.6 Ralington pharma LLP
10.6.1 Ralington pharma LLP Company Information
10.6.2 Ralington pharma LLP Introduction and Business Overview
10.6.3 Ralington pharma LLP PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Ralington pharma LLP PDE 4 Inhibitors Products Offered
10.6.5 Ralington pharma LLP Recent Development
10.7 Beijing Biolab Technology Co., Ltd.
10.7.1 Beijing Biolab Technology Co., Ltd. Company Information
10.7.2 Beijing Biolab Technology Co., Ltd. Introduction and Business Overview
10.7.3 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Products Offered
10.7.5 Beijing Biolab Technology Co., Ltd. Recent Development
10.8 Nycomed
10.8.1 Nycomed Company Information
10.8.2 Nycomed Introduction and Business Overview
10.8.3 Nycomed PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Nycomed PDE 4 Inhibitors Products Offered
10.8.5 Nycomed Recent Development
10.9 Forest
10.9.1 Forest Company Information
10.9.2 Forest Introduction and Business Overview
10.9.3 Forest PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Forest PDE 4 Inhibitors Products Offered
10.9.5 Forest Recent Development
10.10 Bristol Myers
10.10.1 Bristol Myers Company Information
10.10.2 Bristol Myers Introduction and Business Overview
10.10.3 Bristol Myers PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Bristol Myers PDE 4 Inhibitors Products Offered
10.10.5 Bristol Myers Recent Development
10.11 GSK
10.11.1 GSK Company Information
10.11.2 GSK Introduction and Business Overview
10.11.3 GSK PDE 4 Inhibitors Sales, Revenue and Gross Margin (2024-2024)
10.11.4 GSK PDE 4 Inhibitors Products Offered
10.11.5 GSK Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 PDE 4 Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 PDE 4 Inhibitors Industrial Chain Analysis
11.4 PDE 4 Inhibitors Market Dynamics
11.4.1 PDE 4 Inhibitors Industry Trends
11.4.2 PDE 4 Inhibitors Market Drivers
11.4.3 PDE 4 Inhibitors Market Challenges
11.4.4 PDE 4 Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 PDE 4 Inhibitors Distributors
12.3 PDE 4 Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Rolipram
Table 2. Major Company of Tetomilast
Table 3. Major Company of Cilomilast
Table 4. Major Company of Criborole
Table 5. Major Company of Apremilast
Table 6. Major Company of Roflumilast
Table 7. Major Company of Others
Table 8. Global PDE 4 Inhibitors Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 9. Global PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 10. Global PDE 4 Inhibitors Sales Market Share in Volume by Type (2024-2024)
Table 11. Global PDE 4 Inhibitors Sales by Type (2024-2024) & (US& Million)
Table 12. Global PDE 4 Inhibitors Market Share in Value by Type (2024-2024)
Table 13. Global PDE 4 Inhibitors Price by Type (2024-2024) & (US$/Unit)
Table 14. Global PDE 4 Inhibitors Sales by Type (2024-2034) & (K Units)
Table 15. Global PDE 4 Inhibitors Sales Market Share in Volume by Type (2024-2034)
Table 16. Global PDE 4 Inhibitors Sales by Type (2024-2034) & (US$ Million)
Table 17. Global PDE 4 Inhibitors Sales Market Share in Value by Type (2024-2034)
Table 18. Global PDE 4 Inhibitors Price by Type (2024-2034) & (US$/Unit)
Table 19. North America PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 20. North America PDE 4 Inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 21. Europe PDE 4 Inhibitors Sales (K Units) by Type (2024-2024)
Table 22. Europe PDE 4 Inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 23. Asia-Pacific PDE 4 Inhibitors Sales (K Units) by Type (2024-2024)
Table 24. Asia-Pacific PDE 4 Inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 25. Latin America PDE 4 Inhibitors Sales (K Units) by Type (2024-2024)
Table 26. Latin America PDE 4 Inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 27. Middle East and Africa PDE 4 Inhibitors Sales (K Units) by Type (2024-2024)
Table 28. Middle East and Africa PDE 4 Inhibitors Sales by Type (2024-2024) & (US$ Million)
Table 29. Global PDE 4 Inhibitors Sales by Company (2024-2024) & (K Units)
Table 30. Global PDE 4 Inhibitors Sales Share by Company (2024-2024)
Table 31. Global PDE 4 Inhibitors Revenue by Company (2024-2024) & (US$ Million)
Table 32. Global PDE 4 Inhibitors Revenue Share by Company (2024-2024)
Table 33. Global Market PDE 4 Inhibitors Price by Company (2024-2024) & (US$/Unit)
Table 34. Global PDE 4 Inhibitors Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global PDE 4 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in PDE 4 Inhibitors as of 2022)
Table 37. Date of Key Manufacturers Enter into PDE 4 Inhibitors Market
Table 38. Key Manufacturers PDE 4 Inhibitors Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global PDE 4 Inhibitors Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Global PDE 4 Inhibitors Sales by Region (2024-2024) & (K Units)
Table 42. Global PDE 4 Inhibitors Sales Market Share in Volume by Region (2024-2024)
Table 43. Global PDE 4 Inhibitors Sales by Region (2024-2024) & (US$ Million)
Table 44. Global PDE 4 Inhibitors Sales Market Share in Value by Region (2024-2024)
Table 45. Global PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 46. Global PDE 4 Inhibitors Sales by Region (2024-2034) & (K Units)
Table 47. Global PDE 4 Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 48. Global PDE 4 Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 49. Global PDE 4 Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 50. Global PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 51. Global PDE 4 Inhibitors Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 52. Global PDE 4 Inhibitors Sales by Application (2024-2024) & (K Units)
Table 53. Global PDE 4 Inhibitors Sales Market Share in Volume by Application (2024-2024)
Table 54. Global PDE 4 Inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 55. Global PDE 4 Inhibitors Sales Market Share in Value by Application (2024-2024)
Table 56. Global PDE 4 Inhibitors Price by Application (2024-2024) & (US$/Unit)
Table 57. Global PDE 4 Inhibitors Sales by Application (2024-2034) & (K Units)
Table 58. Global PDE 4 Inhibitors Sales Market Share in Volume by Application (2024-2034)
Table 59. Global PDE 4 Inhibitors Sales by Application (2024-2034) & (US$ Million)
Table 60. Global PDE 4 Inhibitors Sales Market Share in Value by Application (2024-2034)
Table 61. Global PDE 4 Inhibitors Price by Application (2024-2034) & (US$/Unit)
Table 62. North America PDE 4 Inhibitors Sales by Application (2024-2024) (K Units)
Table 63. North America PDE 4 Inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 64. Europe PDE 4 Inhibitors Sales by Application (2024-2024) (K Units)
Table 65. Europe PDE 4 Inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 66. Asia-Pacific PDE 4 Inhibitors Sales by Application (2024-2024) (K Units)
Table 67. Asia-Pacific PDE 4 Inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 68. Latin America PDE 4 Inhibitors Sales by Application (2024-2024) (K Units)
Table 69. Latin America PDE 4 Inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 70. Middle East and Africa PDE 4 Inhibitors Sales by Application (2024-2024) (K Units)
Table 71. Middle East and Africa PDE 4 Inhibitors Sales by Application (2024-2024) & (US$ Million)
Table 72. North America PDE 4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 73. North America PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 74. North America PDE 4 Inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 75. North America PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2024)
Table 76. North America PDE 4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 77. North America PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 78. North America PDE 4 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 79. North America PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 80. Europe PDE 4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 81. Europe PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 82. Europe PDE 4 Inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 83. Europe PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2024)
Table 84. Europe PDE 4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 85. Europe PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe PDE 4 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific PDE 4 Inhibitors Sales by Region (2024-2024) & (K Units)
Table 89. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Volume by Region (2024-2024)
Table 90. Asia-Pacific PDE 4 Inhibitors Sales by Region (2024-2024) & (US$ Million)
Table 91. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Value by Region (2024-2024)
Table 92. Asia-Pacific PDE 4 Inhibitors Sales by Region (2024-2034) & (K Units)
Table 93. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific PDE 4 Inhibitors Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America PDE 4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 97. Latin America PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 98. Latin America PDE 4 Inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 99. Latin America PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2024)
Table 100. Latin America PDE 4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 101. Latin America PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America PDE 4 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa PDE 4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 105. Middle East and Africa PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2024)
Table 106. Middle East and Africa PDE 4 Inhibitors Sales by Country (2024-2024) & (US$ Million)
Table 107. Middle East and Africa PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2024)
Table 108. Middle East and Africa PDE 4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 109. Middle East and Africa PDE 4 Inhibitors Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa PDE 4 Inhibitors Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa PDE 4 Inhibitors Sales Market Share in Value by Country (2024-2034)
Table 112. Pfizer(Anacor) Company Information
Table 113. Pfizer(Anacor) Introduction and Business Overview
Table 114. Pfizer(Anacor) PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Pfizer(Anacor) PDE 4 Inhibitors Product
Table 116. Pfizer(Anacor) Recent Development
Table 117. Arcutis Biotherapeutics Company Information
Table 118. Arcutis Biotherapeutics Introduction and Business Overview
Table 119. Arcutis Biotherapeutics PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Arcutis Biotherapeutics PDE 4 Inhibitors Product
Table 121. Arcutis Biotherapeutics Recent Development
Table 122. UNION Therapeutics Company Information
Table 123. UNION Therapeutics Introduction and Business Overview
Table 124. UNION Therapeutics PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. UNION Therapeutics PDE 4 Inhibitors Product
Table 126. UNION Therapeutics Recent Development
Table 127. Innovent Biologics, Inc. Company Information
Table 128. Innovent Biologics, Inc. Introduction and Business Overview
Table 129. Innovent Biologics, Inc. PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Innovent Biologics, Inc. PDE 4 Inhibitors Product
Table 131. Innovent Biologics, Inc. Recent Development
Table 132. Amgen Company Information
Table 133. Amgen Introduction and Business Overview
Table 134. Amgen PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Amgen PDE 4 Inhibitors Product
Table 136. Amgen Recent Development
Table 137. Ralington pharma LLP Company Information
Table 138. Ralington pharma LLP Introduction and Business Overview
Table 139. Ralington pharma LLP PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Ralington pharma LLP PDE 4 Inhibitors Product
Table 141. Ralington pharma LLP Recent Development
Table 142. Beijing Biolab Technology Co., Ltd. Company Information
Table 143. Beijing Biolab Technology Co., Ltd. Introduction and Business Overview
Table 144. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product
Table 146. Beijing Biolab Technology Co., Ltd. Recent Development
Table 147. Nycomed Company Information
Table 148. Nycomed Introduction and Business Overview
Table 149. Nycomed PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Nycomed PDE 4 Inhibitors Product
Table 151. Nycomed Recent Development
Table 152. Forest Company Information
Table 153. Forest Introduction and Business Overview
Table 154. Forest PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Forest PDE 4 Inhibitors Product
Table 156. Forest Recent Development
Table 157. Bristol Myers Company Information
Table 158. Bristol Myers Introduction and Business Overview
Table 159. Bristol Myers PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Bristol Myers PDE 4 Inhibitors Product
Table 161. Bristol Myers Recent Development
Table 162. GSK Company Information
Table 163. GSK Introduction and Business Overview
Table 164. GSK PDE 4 Inhibitors Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. GSK PDE 4 Inhibitors Product
Table 166. GSK Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. PDE 4 Inhibitors Market Trends
Table 170. PDE 4 Inhibitors Market Drivers
Table 171. PDE 4 Inhibitors Market Challenges
Table 172. PDE 4 Inhibitors Market Restraints
Table 173. PDE 4 Inhibitors Distributors List
Table 174. PDE 4 Inhibitors Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. PDE 4 Inhibitors Product Picture
Figure 2. Global PDE 4 Inhibitors Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global PDE 4 Inhibitors Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global PDE 4 Inhibitors Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Rolipram
Figure 6. Global Rolipram Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Tetomilast
Figure 8. Global Tetomilast Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Cilomilast
Figure 10. Global Cilomilast Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Criborole
Figure 12. Global Criborole Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Apremilast
Figure 14. Global Apremilast Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Roflumilast
Figure 16. Global Roflumilast Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Product Picture of Others
Figure 18. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 19. Global PDE 4 Inhibitors Sales by Type (2024-2034) & (US$ Million)
Figure 20. Global PDE 4 Inhibitors Sales Market Share by Type in 2022 & 2034
Figure 21. North America PDE 4 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 22. North America PDE 4 Inhibitors Sales Market Share in Value by Type in 2022
Figure 23. Europe PDE 4 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 24. Europe PDE 4 Inhibitors Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Value by Type in 2022
Figure 27. Latin America PDE 4 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 28. Latin America PDE 4 Inhibitors Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa PDE 4 Inhibitors Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa PDE 4 Inhibitors Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by PDE 4 Inhibitors Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by PDE 4 Inhibitors Revenue in 2022
Figure 33. PDE 4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 34. Product Picture of Psoriasis
Figure 35. Global Psoriasis Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Chronic Obstructive Pulmonary Disease (COPD)
Figure 37. Global Chronic Obstructive Pulmonary Disease (COPD) Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Product Picture of Asthma
Figure 39. Global Asthma Sales YoY Growth (2024-2034) & (K Units)
Figure 40. Product Picture of Ankylosing Spondylitis (AS)
Figure 41. Global Ankylosing Spondylitis (AS) Sales YoY Growth (2024-2034) & (K Units)
Figure 42. Product Picture of Inflammatory Bowel Disease (IBD)
Figure 43. Global Inflammatory Bowel Disease (IBD) Sales YoY Growth (2024-2034) & (K Units)
Figure 44. Product Picture of Atopic Dermatitis
Figure 45. Global Atopic Dermatitis Sales YoY Growth (2024-2034) & (K Units)
Figure 46. Product Picture of Rheumatoid Arthritis (RA)
Figure 47. Global Rheumatoid Arthritis (RA) Sales YoY Growth (2024-2034) & (K Units)
Figure 48. Product Picture of Systemic Lupus Erythematosus (SLE)
Figure 49. Global Systemic Lupus Erythematosus (SLE) Sales YoY Growth (2024-2034) & (K Units)
Figure 50. Product Picture of Others
Figure 51. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 52. Global PDE 4 Inhibitors Sales by Application (2024-2034) & (US$ Million)
Figure 53. Global PDE 4 Inhibitors Sales Market Share by Application in 2022 & 2034
Figure 54. North America PDE 4 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 55. North America PDE 4 Inhibitors Sales Market Share in Value by Application in 2022
Figure 56. Europe PDE 4 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 57. Europe PDE 4 Inhibitors Sales Market Share in Value by Application in 2022
Figure 58. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 59. Asia-Pacific PDE 4 Inhibitors Sales Market Share in Value by Application in 2022
Figure 60. Latin America PDE 4 Inhibitors Sales Market Share in Volume by Application in 2022
Figure 61. Latin America PDE 4 Inhibitors Sales Market Share in Value by Application in 2022
Figure 62. Middle East and Africa PDE 4 Inhibitors Sales Market Share in Value by Application in 2022
Figure 63. Key Raw Materials Price
Figure 64. PDE 4 Inhibitors Manufacturing Cost Structure
Figure 65. PDE 4 Inhibitors Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries